US Patent 7550572 siRNA targeting cell division cycle 20 homolog (CDC20)
Patent 7550572 was granted and assigned to Dharmacon, Inc. on June, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7550572 siRNA targeting cell division cycle 20 homolog (CDC20)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.